Molecular genetics in hypertrophic cardiomyopathy;Molekulární genetika u hypertrofické kardiomyopatie

Cor et Vasa

Volumn 49, Issue 4, 2007, Pages 138-142

  Čurila, Karol ^a   Pěnička, Martin ^a   Linková, Hana ^a   Knot, Jiří ^a   Gregor, Pavel ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Genes; Hypertropic cardiomyopathy; Mutation; Sudden death

Indexed keywords

AMINO ACID; CELL PROTEIN;

CLINICAL FEATURE; GENE MUTATION; GENETIC COUNSELING; HEART MUSCLE CELL; HEART STRESS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LIFESPAN; MOLECULAR GENETICS; PRENATAL DIAGNOSIS; PROGNOSIS; REVIEW; RISK ASSESSMENT; SARCOMERE; SCREENING TEST; SUDDEN DEATH;

EID: 34247607710     PISSN: 00108650     EISSN: None     Source Type: Journal    
DOI: 10.33678/cor.2007.052     Document Type: Review

References (43)

1. Gregor P, Widimský P, et al. Kardiologie. Praha: Galen, 1999; 449-59.
2. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrofic cardiomyopathy in a general population of jung adult: echokardiographic analysis of 4111 subject in Kardia study. Circulation 1995;92:785-9.
3. Kofflard MJ, Waldstein DJ, Vos J, Ten Cate FJ. Prognosis in hypertrophic cardiomyopathy observed in large clinic population. Am J Cardiol 1993;72:939-43.
4. Maron BJ, Spirito P, Wesley Y, Arce J. Developement and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. New Engl J Med 1986;315:610-4.
5. Niimura H, Bachinski LL, Bjornsdottir H. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. New Engl J Med 1998;338:1248-57.
6. Maron BJ, Roberts WC, McAllister HA, et al. Sudden death in young athletes. Circulation 1980;62:218-29.
7. Gregor P, Černý M, Červenka V, Víšek V, Widimský P. Hypertrofická kardiomyopatie. Praha: Scientia Medica 1992;260:56-60.
8. Maron BJ, McKenna WJ, Danielson GK, et al. ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology task force on clinical expert consensus documents and the European Society of Cardiology committee for practice guidelines (committee to develop an expert consensus document on hypertrophic cardiomyopathy). J Am Coll Cardiol 2003;42:1965-91.
9. Maron MS, Olivotto I, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. New Engl J Med 2003; 348:295-303.
10. Elliott PM, Gimeno JR, Tome MT, et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 2006;27:1933-41.
11. Maron MS, Olivotto I. Zenovych AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 2006; 114:2232-9.
12. Veselka J, Tesař D, Páleníčková J, et al. Katetrizační léčba hypertrofické obstrukční kardiomyopatie. Cor Vasa 2003;45:80-4.
13. Shimizu M, Ino H, Yamaguchi M, et al. Chronologic electrocardiographic changes in patients with hypertrophic cardiomyopathy associated with cardiac troponin I mutation. Am Heart J 2002;143:289-93.
14. Nagueh SF, Bachinski LL, Meyer D, et al. Tissue doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means an early diagnosis before and independently of hypertrophy. Circulation 2001;104:128-30.
15. Ho CY, Sweitzer NK, McDonough B, et al. Assesment of diastolic function with doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 2002;105:2992-7.
16. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112: 855-61.
17. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-7.
18. Maron BJ, Olivotto T, Spirito P, Cecchi F. Epidemiology of hypertrophic cardiomyopathy-related death revisited in a large non referral based patient population. Circulation 2000;102:858-64.
19. Maron BJ, Shen WK, Link MS, et al. Efficacy of implantable cardioverter-defibrilators for prevention of sudden death in patients with hypertrophic cardiomyopathy. New Engl J Med 2000;342:365-73.
20. Frenneaux MP. Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart 2004;90:570-5.
21. Jarcho JA, McKenna W, Pare JA, et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. New Engl J Med 1989;321:1372-8.
22. Rosenzweig A, Watkins H, Seidman CH, et al. Preclinical diagnosis of familiar hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes. New Engl J Med 1991;325:1753-60.
23. Solomon SD, Jarcho JA, McKenna W, et al. Familiar hypertrophic cardiomyopathy is a genetically heterogenous disease. J Clin Invest 1990;86:993-100.
24. Fatkin D, Graham RM. Molecular mechanisms of inherited cardiomyopathies. Physiol Rev 2002;80:945-80.
25. Song L, Zou Y, Wang J, et al. Mutation profile in Chinese patients with hypertrophic cardiomyopathy. Clinica Chimica Acta 2005;351:209-16.
26. Van Driest SL, Ellsworth EG, Ommen SR, et al. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation 2003;108:445-51.
27. Erdmann J, Daehmlow S, Regitz-Zagrosek V, et al. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clin Genet 2003;64:339-49.
28. Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy. Distribution of disease genes, spectrum of mutations and implications for a molecular diagnosis strategy. Circulation 2003;107:2227-32.
29. Watkins H. Hypertrophic cardiomyopathy: from molecular and genetic mechanism to clinical management. Eur Heart J 2001;3 Suppl:43-50.
30. Watkins H, McKenna W, Seidman E, et al. Mutations in the genes for cardiac troponin T and alfa-tropomyosin in hypertrophic cardiomyopathy. New Engl J Med 1995; 332:1058-64.
31. Geier C, Perrot A, Ozcelik C, et al. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 2003;107:1390-5.
32. Bos JM, Poley RN, Ny M, et al. Genotype - phenotype relationships involving hypertrophic cardiomyopathy - associated mutations in titin, muscle LIM protein, and telethonin. Mol Genet Metab 2006;88:78-85.
33. Anal R, Greve G, Thierfelder L, et al. Prognostic implication of novel beta cardiac myosin haevy chain gene mutation that cause familiar hypertrophic cardiomyopathy. J Clin Invest 1994;93:280-5.
34. Ackerman M, VanDriest S, Gersch J. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39:2042-8.
35. http://fig.cox.miami.edu/~cmallery/150/neuro/myosin.jpg
36. Woo A, Rakowski H, Sole MJ. Mutation of the beta-myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis. Heart 2003;89:1179-85.
37. Ingles J, Doolan A, Seidman J, Semsarian Ch. Compound and double mutation in hypertrophic cardiomyopathy patients: implication for genetic testing and councelling. Circulation 2005;112:412.
38. Roberts R, Sigwart U. Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy. Circulation 2005;112:293-296.
39. Ho C, Seidman CHE. A contemporary approach to hypertrophic cardiomyopathy. Circulation 2006;113:858-62.
40. Charron P, Heron D, Richard P, Komajda M. Prenatal molecular diagnosis in hypertrophic cardiomyopathy: report of the first case. Prenatal diagnosis 2004;24:701-3.
41. Maron BJ. Pelliccia A, Spirito P. Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 1995:91;1596-601.
42. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes: Clinical, demographic and pathological profiles. JAMA 1996;276:199-204.
43. Maron BJ. Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance. Heart 2005;91:1380-2.